Adriamycin
Product Images NDC 0143-9372

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Adriamycin (NDC 0143-9372). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adriamycin Injection Structural Formula (Adriamycin Doxorubicin HCl Injection Novaplus 1)

FDA Label Image

Figure 1 (Adriamycin Doxorubicin HCl Injection Novaplus 2)

FDA Label Image

Figure 2 (Adriamycin Doxorubicin HCl Injection Novaplus 3)

Figure 2 (Adriamycin Doxorubicin HCl Injection Novaplus 3)
This appears to be a table or a chart containing information on Hazard Ratio, Trials, and their respective results. The table includes information on several trials such as NSABP B-15, SECSG 2, ONCOFRANCE, SE Sweden BCG A, NSABC Israel Br0283, and Austrian BCSG 3. Additionally, there seems to be a comparison of six studies based on Doxo efficacy in comparison to GMF and CMP. The results show that Doxo is better than GMF but worse than CMP in some cases.*
FDA Label Image

Adriamycin Injection 10 mg/5 mL Label (Adriamycin Doxorubicin HCl Injection Novaplus 4)

FDA Label Image

Adriamycin Injection 20 mg/10 mL Label (Adriamycin Doxorubicin HCl Injection Novaplus 5)

FDA Label Image

Adriamycin Injection 50 mg/25 mL Label (Adriamycin Doxorubicin HCl Injection Novaplus 6)

FDA Label Image

Adriamycin Injection 200 mg/100 mL Label (Adriamycin Doxorubicin HCl Injection Novaplus 7)

Adriamycin Injection 200 mg/100 mL Label (Adriamycin Doxorubicin HCl Injection Novaplus 7)
Product: ADRIAMYCIN (DOXOrubicin Hel) Injection, USP for Intravenous Use Only. It is a multiple-dose vial and should be used with caution. The drug is distributed under the brand name novaplus. The remaining text is not readable.*
FDA Label Image

Representative Serialization Image (Adriamycin Doxorubicin HCl Injection Novaplus 8)

Representative Serialization Image (Adriamycin Doxorubicin HCl Injection Novaplus 8)
This is a product label with information regarding the GTIN (Global Trade Item Number), serial number (SN), expiry date (EXP), and lot number (LOT). The GTIN is a barcode used to identify the product in global trade, while the SN is a unique identifier for the specific unit of the product. The EXP indicates the month (MMM) and year (YYYY) in which the product is no longer recommended for use, and the LOT number is a unique identifier assigned to a batch of the product.*
FDA Label Image

Representative Serialization Image (Adriamycin Doxorubicin HCl Injection Novaplus 9)

Representative Serialization Image (Adriamycin Doxorubicin HCl Injection Novaplus 9)
This is a product code and identification number. The lot number is "ABCDE12345" and the expiration date is "MMMYYYY". The Global Trade Item Number (GTIN) is "00301234567896" and the serial number (SN) is "12345678901234".*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.